MIKAILA LUGO-SCHLEGEL: Open Payments
NPI 1346959129 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,102 in 175 payments from 15 companies in 2025. Trend: 2023 $2,661 · 2024 $3,136 · 2025 $3,102
Food & beverage: $2,934Education: $168
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 37 | $1,077 |
| Otsuka America Pharmaceutical, Inc. | 41 | $530 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $391 |
| Alkermes, Inc. | 20 | $301 |
| Supernus Pharmaceuticals, Inc. | 15 | $186 |
| Neurocrine BioSciences, Inc. | 13 | $180 |
| Janssen Pharmaceuticals, Inc | 5 | $87 |
| E.R. Squibb & Sons, L.L.C. | 5 | $87 |
| Axsome Therapeutics, Inc. | 4 | $77 |
| ABBVIE INC. | 3 | $53 |
Products named: UZEDY, REXULTI, CAPLYTA, AUSTEDO XR, LYBALVI, Qelbree, INGREZZA, ABILIFY ASIMTUFII.
Industry payments across PA — which companies pay providers there.
